Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.
from NCI News Releases https://ift.tt/2ArTaMn
from NCI News Releases https://ift.tt/2ArTaMn